Literature DB >> 23460515

Murine vaginal colonization model for investigating asymptomatic mucosal carriage of Streptococcus pyogenes.

Michael E Watson1, Hailyn V Nielsen, Scott J Hultgren, Michael G Caparon.   

Abstract

While many virulence factors promoting Streptococcus pyogenes invasive disease have been described, specific streptococcal factors and host properties influencing asymptomatic mucosal carriage remain uncertain. To address the need for a refined model of prolonged S. pyogenes asymptomatic mucosal colonization, we have adapted a preestrogenized murine vaginal colonization model for S. pyogenes. In this model, derivatives of strains HSC5, SF370, JRS4, NZ131, and MEW123 established a reproducible, asymptomatic colonization of the vaginal mucosa over a period of typically 3 to 4 weeks' duration at a relatively high colonization efficiency. Prior treatment with estradiol prolonged streptococcal colonization and was associated with reduced inflammation in the colonized vaginal epithelium as well as a decreased leukocyte presence in vaginal fluid compared to the levels of inflammation and leukocyte presence in non-estradiol-treated control mice. The utility of our model for investigating S. pyogenes factors contributing to mucosal carriage was verified, as a mutant with a mutation in the transcriptional regulator catabolite control protein A (CcpA) demonstrated significant impairment in vaginal colonization. An assessment of in vivo transcriptional activity in the CcpA(-) strain for several known CcpA-regulated genes identified significantly elevated transcription of lactate oxidase (lctO) correlating with excessive generation of hydrogen peroxide to self-lethal levels. Deletion of lctO did not impair colonization, but deletion of lctO in a CcpA(-) strain prolonged carriage, exceeding even that of the wild-type strain. Thus, while LctO is not essential for vaginal colonization, its dysregulation is deleterious, highlighting the critical role of CcpA in promoting mucosal colonization. The vaginal colonization model should prove effective for future analyses of S. pyogenes mucosal colonization.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23460515      PMCID: PMC3648019          DOI: 10.1128/IAI.00021-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  77 in total

1.  Expression of uterine and cervical epithelial cadherin during relaxin-induced growth in pigs.

Authors:  P L Ryan; D L Baum; J A Lenhart; K M Ohleth; C A Bagnell
Journal:  Reproduction       Date:  2001-12       Impact factor: 3.906

2.  Contribution of NADH oxidase to aerobic metabolism of Streptococcus pyogenes.

Authors:  C M Gibson; T C Mallett; A Claiborne; M G Caparon
Journal:  J Bacteriol       Date:  2000-01       Impact factor: 3.490

3.  Genome sequence of a serotype M28 strain of group a streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity.

Authors:  Nicole M Green; Shizhen Zhang; Stephen F Porcella; Michal J Nagiec; Kent D Barbian; Stephen B Beres; Rance B LeFebvre; James M Musser
Journal:  J Infect Dis       Date:  2005-07-29       Impact factor: 5.226

4.  Anal carriage as the probable source of a streptococcal epidemic.

Authors:  W M McKee; J M Di Caprio; C E Roberts; J C Sherris
Journal:  Lancet       Date:  1966-11-05       Impact factor: 79.321

5.  Complete genome sequence of an M1 strain of Streptococcus pyogenes.

Authors:  J J Ferretti; W M McShan; D Ajdic; D J Savic; G Savic; K Lyon; C Primeaux; S Sezate; A N Suvorov; S Kenton; H S Lai; S P Lin; Y Qian; H G Jia; F Z Najar; Q Ren; H Zhu; L Song; J White; X Yuan; S W Clifton; B A Roe; R McLaughlin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

6.  CcpA-mediated repression of Clostridium difficile toxin gene expression.

Authors:  Ana Antunes; Isabelle Martin-Verstraete; Bruno Dupuy
Journal:  Mol Microbiol       Date:  2010-12-28       Impact factor: 3.501

Review 7.  Lactational amenorrhea as a risk factor for group a streptococcal vaginitis.

Authors:  Micelle C Meltzer; Jane R Schwebke
Journal:  Clin Infect Dis       Date:  2008-05-15       Impact factor: 9.079

8.  SpxB is a suicide gene of Streptococcus pneumoniae and confers a selective advantage in an in vivo competitive colonization model.

Authors:  Gili Regev-Yochay; Krzysztof Trzcinski; Claudette M Thompson; Marc Lipsitch; Richard Malley
Journal:  J Bacteriol       Date:  2007-07-13       Impact factor: 3.490

9.  Vulvovaginitis in prepubertal girls.

Authors:  T Stricker; F Navratil; F H Sennhauser
Journal:  Arch Dis Child       Date:  2003-04       Impact factor: 3.791

10.  Conversion of an M- group A streptococcus to M+ by transfer of a plasmid containing an M6 gene.

Authors:  J R Scott; P C Guenthner; L M Malone; V A Fischetti
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

View more
  22 in total

1.  Streptococcus pyogenes malate degradation pathway links pH regulation and virulence.

Authors:  Elyse Paluscio; Michael G Caparon
Journal:  Infect Immun       Date:  2015-01-12       Impact factor: 3.441

2.  A Mobile Genetic Element Promotes the Association Between Serotype M28 Group A Streptococcus Isolates and Cases of Puerperal Sepsis.

Authors:  Ira Jain; Poulomee Sarkar; Jessica L Danger; Josette Medicielo; Roshika Roshika; Gregory Calfee; Anupama Ramalinga; Cameron Burgess; Paul Sumby
Journal:  J Infect Dis       Date:  2019-07-31       Impact factor: 5.226

Review 3.  Evolutionary Constraints Shaping Streptococcus pyogenes-Host Interactions.

Authors:  Reid V Wilkening; Michael J Federle
Journal:  Trends Microbiol       Date:  2017-02-16       Impact factor: 17.079

4.  The Integrative Conjugative Element ICESpyM92 Contributes to Pathogenicity of Emergent Antimicrobial-Resistant emm92 Group A Streptococcus.

Authors:  Luis Alberto Vega; Misu A Sanson; María Belén Cubria; Shrijana Regmi; Brittany J Shah; Samuel A Shelburne; Anthony R Flores
Journal:  Infect Immun       Date:  2022-08-01       Impact factor: 3.609

Review 5.  Stress Physiology of Lactic Acid Bacteria.

Authors:  Konstantinos Papadimitriou; Ángel Alegría; Peter A Bron; Maria de Angelis; Marco Gobbetti; Michiel Kleerebezem; José A Lemos; Daniel M Linares; Paul Ross; Catherine Stanton; Francesca Turroni; Douwe van Sinderen; Pekka Varmanen; Marco Ventura; Manuel Zúñiga; Effie Tsakalidou; Jan Kok
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-27       Impact factor: 11.056

6.  A Novel Heme Transporter from the Energy Coupling Factor Family Is Vital for Group A Streptococcus Colonization and Infections.

Authors:  Nilanjana Chatterjee; Laura C C Cook; Kristin V Lyles; Hong Anh T Nguyen; Darius J Devlin; Lamar S Thomas; Zehava Eichenbaum
Journal:  J Bacteriol       Date:  2020-06-25       Impact factor: 3.490

7.  Streptococcus pyogenes arginine and citrulline catabolism promotes infection and modulates innate immunity.

Authors:  Zachary T Cusumano; Michael E Watson; Michael G Caparon
Journal:  Infect Immun       Date:  2013-10-21       Impact factor: 3.441

8.  Genome-Wide Screens Identify Group A Streptococcus Surface Proteins Promoting Female Genital Tract Colonization and Virulence.

Authors:  Luchang Zhu; Randall J Olsen; Stephen B Beres; Matthew Ojeda Saavedra; Samantha L Kubiak; Concepcion C Cantu; Leslie Jenkins; Prasanti Yerramilli; Layne Pruitt; Amelia R L Charbonneau; Andrew S Waller; James M Musser
Journal:  Am J Pathol       Date:  2020-03-19       Impact factor: 4.307

9.  Influence of the Alternative Sigma Factor RpoN on Global Gene Expression and Carbon Catabolism in Enterococcus faecalis V583.

Authors:  Erica C Keffeler; Vijayalakshmi S Iyer; Srivatsan Parthasarathy; Matthew M Ramsey; Matthew J Gorman; Theresa L Barke; Sriram Varahan; Sally Olson; Michael S Gilmore; Zakria H Abdullahi; Emmaleigh N Hancock; Lynn E Hancock
Journal:  mBio       Date:  2021-05-18       Impact factor: 7.867

10.  Complete Genome Sequence of emm Type 14 Streptococcus pyogenes Strain HSC5.

Authors:  Gary C Port; Elyse Paluscio; Michael G Caparon
Journal:  Genome Announc       Date:  2013-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.